[Lab] split one vial across Janoshik and Medutest — 95.1% and 99.3%
split one vial across Janoshik and Medutest — 95.1% and 99.3%. I will put the method line and the batch identifier up front because that is what makes this checkable. 95.1% and 99.3%. Those are measured, not estimated, and not rounded up in my favour. It is a triple agonist at the GLP-1, GIP and glucagon receptors.…
Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.
nothing here is available as a prescription product, so read every thread with that in mind
the TRIUMPH programme is still running, so anything definitive is premature
phase 2 data only, and people quote it like it is a label
The thing that surprised me was how much of the discussion here is inference rather than measurement.
Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.
a lot of the confident posting here is extrapolation
Disagree. "More receptors means more effect" is not how any of this works and the trial data does not support the linear story.
comparing reta phase 2 to sema phase 3 is comparing different things